242 Participants Needed

Corticosteroids for Asthma

(AirPATH Trial)

Recruiting at 1 trial location
SS
YF
Overseen ByYonni Friedlander, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

Most individuals with asthma can effectively manage their symptoms and maintain normal lung function using inhaled medications, unfortunately, there is a subset of asthma sufferers whose symptoms, lung function, and risk of asthma attacks remain unimproved despite conventional inhaled medications. There could be several reasons for this. One possibility is that inhaled medications fail to reach the intended areas within the lungs, due to structural abnormalities within the airways themselves. Much like road conditions or closures can impede the speed and efficiency of vehicle travel, factors such as airway narrowing or mucus blockages, which are common in asthma, can obstruct the passage of inhaled medications through the airways. Our team has now optimized advanced medical imaging techniques, including magnetic resonance imaging (MRI) and computed tomography (CT), required to investigate this. This study will use these imaging methods to visually assess and measure individual patients' airways and determine whether abnormal airway structures impact how well they respond to inhaled and orally delivered medications. We anticipate finding that abnormal airway structures make inhaled medications less effective, but that they do not affect the response to oral medications.

Eligibility Criteria

This trial is for asthma patients who don't get better with regular inhaled meds. It's likely because the meds can't reach all parts of their lungs due to airway issues like narrowing or mucus. To join, they need a detailed lung scan using MRI or CT.

Inclusion Criteria

Able and willing to provide written informed consent
Able and willing to comply with the study protocol
ACQ ≥1.5 during the screening period
See 3 more

Exclusion Criteria

Non-English speaking
Unable to undergo MRI due to implanted devices or metal in body, severe claustrophobia, or other conditions preventing MRI performance.
Pregnant or breastfeeding
See 5 more

Treatment Details

Interventions

  • Inhaled corticosteroid (ICS)
  • Oral Corticosteroid (OCS)
Trial Overview The study tests if abnormal airways affect how well inhaled and oral asthma meds work. Using advanced imaging (MRI/CT), researchers will see if these structural problems make inhaled drugs less effective compared to oral ones.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Uncontrolled eosinophilic asthmaExperimental Treatment2 Interventions
In Phase I, participants will receive a doubling of their current ICS dose. If their asthma remains uncontrolled, they will receive an OCS burst in phase II.

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security